Turning Point Therapeutics Inc (TPTX) stock has fallen -57.23% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives TPTX stock a score of 34 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 7. TPTX's rank also includes a short-term technical score of 10. The fundamental score for TPTX is 84. In addition to the average rating from Wall Street analysts, TPTX stock has a mean target price of $114.33. This means analysts expect the stock to gain 305.44% over the next 12 months. TPTX has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on TPTX!